What is Fisher & Paykel Healthcare Corporation Limited (FSPKF)?

Fisher & Paykel Healthcare Corporation Limited (FSPKF) is a stock in the Healthcare sector, Medical - Instruments & Supplies industry. View full analysis on Stocks360.

What is the current price of FSPKF?

The current price of FSPKF is $28.09. Prices are updated in real time on Stocks360.

What is FSPKF's price-to-earnings (PE) ratio?

FSPKF's trailing twelve-month PE ratio is 59.57, based on current price and earnings per share data available on Stocks360.

What is FSPKF's market capitalization?

FSPKF's market capitalization is $16,524,363,850.00, placing it in the large-cap tier.

Does FSPKF pay a dividend?

Yes. FSPKF has a trailing twelve-month dividend yield of 0.01%. Dividend data is sourced from financial market providers and displayed on Stocks360.

Fisher & Paykel Healthcare Corporation Limited (FSPKF)

Stock analysis · OTC · Healthcare · Medical - Instruments & Supplies

$28.09

Market Cap

$16.52B

PE (TTM)

59.57

EPS (TTM)

N/A

Dividend Yield

1.16%

Beta

0.89

Day Range

$28.09 – $30.21

52-wk Range

$19.01 – $30.21

Avg Volume

N/A

Volume

4.00

Fisher & Paykel Healthcare Corporation Limited (FSPKF) is a publicly traded company in the Healthcare sector. Latest price: $28.09. Market cap $16.52B. Trailing PE 59.57. Dividend yield 1.16%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-30 · $20.95 2026-10-29 · $28.09 (+34.08%)

Earnings

Most Recent

May 26, 2026

EPS $0.25 vs est. $0.24

Beat by $0.01

Next Earnings

Nov 26, 2026

EPS estimate $0.00

Proprietary Signals

Signal snapshot temporarily unavailable.

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, specializes in the global development, manufacturing, marketing, and distribution of sophisticated medical device products and systems. The company's offerings are crucial for acute and chronic respiratory care, surgical support, and the management of obstructive sleep apnea (OSA) in both clinical and home environments. Its product portfolio features advanced solutions such as the Airvo 2 humidified high-flow nasal system, Optiflow nasal high-flow therapy, and the F&P 850 System for both non-invasive and invasive ventilation. Additionally, Fisher & Paykel Healthcare provides specialized infant respiratory products, encompassing resuscitation devices, continuous positive airway pressure (CPAP) therapy, and nasal high-flow therapy solutions for pediatric patients. The company further supplies a comprehensive range of hospital-grade items, including humidification units, breathing circuits, chambers, masks, nasal cannulas, surgical components, and various interfaces and accessories. For homecare, it offers a diverse collection of masks, CPAP machines, software for data management, humidifiers, and other r…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	59.57×
P/S (TTM)	11.97×
P/B	13.22×
PEG	1.67×
P/FCF (TTM)	57.08×
EV / EBITDA	33.89×
EV / Sales	11.83×
Earnings Yield	1.67%
Free Cash Flow Yield	1.75%
Dividend Yield	1.16%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$27.68B
Revenue (TTM)	$2.34B
Net Income (TTM)	$468.79M
Free Cash Flow (TTM)	$475.64M
Net Debt	-$315.00M
Working Capital	$654.40M
Gross Margin	64.16%
Operating Margin	28.52%
Net Margin	20.03%
Return on Equity	22.84%
Return on Invested Capital	20.72%